News Articles

Displaying 1 through 8 of 73  Next Page >>
March is National Essential Tremor month
Thursday, March 28, 2019
Did you know March is National Essential Tremor month? Essential tremor (ET) is often mistaken for Parkinson’s disease, yet it is eight times more common. ET is a neurological condition typically marked by tremors in the hands, head, and/or voice. Approximately 10 million Americans have ET, with symptoms beginning at any age. Our movement disorders
Parkinson's In the National Spotlight
Thursday, January 24, 2019
Parkinson’s Institute and Clinical Center (PICC) is featured in this educational piece, graciously sponsored by Adamas Pharmaceuticals, Inc., highlighting PICC’s mission, causes of Parkinson’s, treatment, and current research. Click here to see a six minute video about the Adamas clinical studies conducted at the Parkinson's Institute and
Parkinson's Institute Appoints Mr. Brian Coulter as CEO
Friday, January 11, 2019
The Parkinson’s Institute and Clinical Center has appointed former Chief Operating Officer, Brian Coulter as Chief Executive Officer. Brian replaces Dr. Carrolee Barlow, Brian Coulter is a seasoned Chief Operating Officer with experience in the non-profit sector, forprofit sector, and federal government. With a formal education in finance, real
Cheryl Gardner joins Parkinson's Institute as the Vice President of Philanthropic Services
Friday, August 31, 2018
Parkinson’s Institute and Clinical Center is excited to welcome Cheryl Gardner as our new Vice President of Philanthropic Services. Cheryl is a seasoned executive who has worked with nonprofit organizations for nearly 20 years, helping them build and increase revenue streams, establish networks, manage resources, raise awareness, and create and
Parkinsonís Institute and Clinical Center and Axial Biotherapeutics Announce Collaboration to Target Gastrointestinal Metabolites that May Contribute to Parkinsonís Disease
Friday, June 29, 2018
Parkinson’s Institute and Clinical Center (PICC) and Axial Biotherapeutics announced today a collaboration to investigate interventions targeting gastrointestinal (GI) metabolites that may cause Parkinson’s Disease (PD). The interventions, to be developed and identified by Axial, will build on the work of Axial’s scientific Co-founder and
Parkinsonís Institute and Clinical Center Collaborates with Kainos Medicine, Korea for Parkinsonís New Drug Treatment Therapies
Friday, June 29, 2018
Parkinson’s Institute and Clinical Center announced today that it is collaborating with Kainos Medicine, Korea on a new drug therapy. Kainos Medicine recently developed KM-819, which is an innovative new investigational drug based on a novel mode of action that protects dopaminergic neurons from death by inhibiting the function of FAF1 which is known
2018 Drive Toward a Cure Road Rally Puts the Pedal to the Metal Against Parkinsonís
Tuesday, June 19, 2018
“Live in the moment, enjoy the day, make the most of what you have,” once stated Michael J. Fox, celebrated actor and influencer who is currently waging war on Parkinson’s disease. His words could have been the mantra for a band of motorists that recently joined the fight against the insidious condition by raising awareness through the
The Parkinsonís Institute and Clinical Center and Denali Therapeutics announced a partnership to explore endpoints studies of patients with Parkinsonís Disease.
Monday, March 19, 2018
The Institute and Denali aim to support the development of new PD therapeutics by better understanding the potential of new endpoints for clinical studies. Known clinical endpoints for PD can be affected by current standard treatments which, in turn, may confound the measurement of new therapeutics’ impact. The agreement brings together the unique
Next Page >>
2500 Hospital Drive, Bldg #10, Suite 1 | Mountain View, CA 94040
650.770.0201 main | 650.770.0204 fax (Clinic Secure)